Target intelligence / Profile preview

Enterotoxigenic Escherichia coli colonization factor antigen (CFA, or CS)

Target
CFA, or CS
Molecular classification
Pilus/fimbriae (bacterial surface adhesin), Chaperone-usher assembled pilus (CU pili), Non-fimbrial/bacterial adhesin (afimbrial adhesin), Outer membrane protein (for some antigens)
01

Overview

Enterotoxigenic Escherichia coli surface antigens denote a highly diverse group of surface-exposed proteins critical for the initial binding and colonization of the human small intestine by ETEC. The best-characterized among these are the colonization factors (CFs) or coli surface antigens (CSs), which include several families of pili/fimbriae (such as CFA/I, CS3, CS23, CS26), assembled via the chaperone-usher pathway, as well as afimbrial adhesins. These antigens function primarily as adhesins, facilitating ETEC attachment to intestinal epithelial cells—an essential prerequisite for the subsequent delivery of enterotoxins (heat-labile and heat-stable toxins) that cause secretory diarrhea. Targeting these surface molecules has driven modern ETEC vaccine development, with antigens like CFA/I tip adhesin (CfaE) and YghJ being explored for recombinant subunit vaccines. Due to their central role in pathogenesis and immunogenicity, ETEC surface antigens are considered premier targets for both prophylactic and therapeutic interventions, although high antigenic variability and presence in nonpathogenic strains complicate universal targeting

Other names
Coli surface antigen(s)Colonization factor(s)Adhesive fimbriaePili/fimbriae (ETEC-specific)Molecular names (e.g., CFA/I, CS3, CS23, CS26)
02

Mechanism of action

Vaccines/antibodies: Block bacterial adhesion to host epithelial cells and prevent colonization and subsequent toxin delivery Transcriptional inhibitors (experimental): Block expression of CF antigens by targeting regulatory proteins (e.g., Rns via decanoic acid)

03

Biological functions

Adherence to host epithelial cellsColonization of the intestinal mucosaBiofilm formation (for certain antigens)Facilitation of toxin delivery and pathogenesis
04

Disease associations

Infection (specifically diarrheal disease in humans)
05

Safety considerations

Antigenic diversity: Many CF and CS antigens, high variability between strains, and existence of nonclassical/mosaic variants pose major challenges for broad vaccine coverageCross-reactivity: Some antigens share epitopes resulting in cross-reactivity, complicating both diagnostics and vaccine formulationsPotential off-target immunity: Some conserved antigens are found in commensal strains
06

Interacting drugs

Not conventional small-molecule drugs; vaccine candidates and neutralizing antibodies targeting specific fimbriae/adhesins (e.g., CFA/I tip adhesin CfaE, anti-CS antibodies)
07

Biomarkers

Expression of specific colonization factor antigens (e.g., CFA/I, CS3, CS23, CS26) detectable by immunological assays or PCR for patient or strain identification and vaccine efficacy monitoring

Beyond the preview

Go deeper on Enterotoxigenic Escherichia coli colonization factor antigen (CFA, or CS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterotoxigenic Escherichia coli colonization factor antigen (CFA, or CS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call